GeneDx Adds Diagnostic Exome Sequencing to Portfolio; Says Disease Gene Panels Still Have Role | GenomeWeb

By Julia Karow

Although GeneDx is planning to launch a diagnostic exome sequencing test to provide answers for patients who have gone through a "diagnostic odyssey", the company does not believe exome sequencing will replace more focused disease gene panels anytime soon.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.